Production (Stage)
Lotus Pharmaceuticals, Inc.
LTUS
$0.005
-$0.0009-15.25%
OTC PK
| 09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | 09/30/2010 | |
|---|---|---|---|---|---|
| Net Income | 1.74M | 7.18M | 11.73M | 14.42M | 20.64M |
| Total Depreciation and Amortization | 2.14M | 2.18M | 2.21M | 2.25M | 2.24M |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 0.00 | 203.80K | 619.90K |
| Total Other Non-Cash Items | 9.60M | 9.81M | 10.02M | 8.13M | 3.36M |
| Change in Net Operating Assets | 4.90M | 5.35M | 4.11M | 1.77M | -1.77M |
| Cash from Operations | 18.37M | 24.52M | 28.07M | 26.78M | 25.09M |
| Capital Expenditure | -19.17M | -24.80M | -27.96M | -29.45M | -17.82M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -8.96M |
| Cash from Investing | -19.17M | -24.80M | -27.96M | -29.45M | -26.78M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 64.20K | 86.00K | 74.80K | 67.10K | 27.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -738.70K | -192.30K | 185.70K | -2.61M | -1.66M |